Olga Shilova - Search Results

Year	Number of Results
2013	1
2016	1
2017	1
2018	1
2019	1
2021	3
2022	1
2024	0

1

Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology.

Shilova O, Kotelnikova P, Proshkina G, Shramova E, Deyev S. Shilova O, et al. Molecules. 2021 Nov 10;26(22):6785. doi: 10.3390/molecules26226785. Molecules. 2021. PMID: 34833876 Free PMC article. Review.

2

Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology.

Shilova O, Shramova E, Proshkina G, Deyev S. Shilova O, et al. Int J Mol Sci. 2021 May 7;22(9):4975. doi: 10.3390/ijms22094975. Int J Mol Sci. 2021. PMID: 34067057 Free PMC article. Review.

3

Disassembling a cancer puzzle: Cell junctions and plasma membrane as targets for anticancer therapy.

Shilova ON, Shilov ES, Lieber A, Deyev SM. Shilova ON, et al. J Control Release. 2018 Sep 28;286:125-136. doi: 10.1016/j.jconrel.2018.07.030. Epub 2018 Jul 17. J Control Release. 2018. PMID: 30030181 Review.

4

Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission.

Shipunova VO, Belova MM, Kotelnikova PA, Shilova ON, Mirkasymov AB, Danilova NV, Komedchikova EN, Popovtzer R, Deyev SM, Nikitin MP. Shipunova VO, et al. Among authors: shilova on. Pharmaceutics. 2022 May 8;14(5):1013. doi: 10.3390/pharmaceutics14051013. Pharmaceutics. 2022. PMID: 35631598 Free PMC article.

5

The effect of trypan blue treatment on autofluorescence of fixed cells.

Shilova ON, Shilov ES, Deyev SM. Shilova ON, et al. Cytometry A. 2017 Sep;91(9):917-925. doi: 10.1002/cyto.a.23199. Epub 2017 Aug 30. Cytometry A. 2017. PMID: 28857464 Free article.

6

HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model.

Sokolova EA, Shilova ON, Kiseleva DV, Schulga AA, Balalaeva IV, Deyev SM. Sokolova EA, et al. Among authors: shilova on. Int J Mol Sci. 2019 May 15;20(10):2399. doi: 10.3390/ijms20102399. Int J Mol Sci. 2019. PMID: 31096563 Free PMC article.

7

Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers' Performance In Vitro and In Vivo.

Shipunova VO, Kovalenko VL, Kotelnikova PA, Sogomonyan AS, Shilova ON, Komedchikova EN, Zvyagin AV, Nikitin MP, Deyev SM. Shipunova VO, et al. Among authors: shilova on. Pharmaceutics. 2021 Dec 26;14(1):43. doi: 10.3390/pharmaceutics14010043. Pharmaceutics. 2021. PMID: 35056939 Free PMC article.

8

Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.

Sokolova E, Proshkina G, Kutova O, Shilova O, Ryabova A, Schulga A, Stremovskiy O, Zdobnova T, Balalaeva I, Deyev S. Sokolova E, et al. Among authors: shilova o. J Control Release. 2016 Jul 10;233:48-56. doi: 10.1016/j.jconrel.2016.05.020. Epub 2016 May 10. J Control Release. 2016. PMID: 27178808

9

Cleavage of the C-S bond with the formation of a binuclear copper complex with 2-thiolato-3-phenyl-5-(pyridine-2-ylmethylene)-3,5-dihydro-4H-imidazole-4-one. A new mimic of the active site of N2O reductase.

Majouga AG, Beloglazkina EK, Moiseeva AA, Shilova OV, Manzheliy EA, Lebedeva MA, Davies ES, Khlobystov AN, Zyk NV. Majouga AG, et al. Among authors: shilova ov. Dalton Trans. 2013 May 14;42(18):6290-3. doi: 10.1039/c3dt50422k. Dalton Trans. 2013. PMID: 23525195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year